The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes - Stitt, A; Gardiner, T A; Alderson, N L; Canning, P; Frizzell, N; Duffy, N; Boyle, C; Januszewski, A S; Chachich, M; Baynes, J W; Thorpe, S R (Diabetes, 2002)